Pharmaceutics International Inc. HQ

Jones Lang LaSalle Americas, Inc. ("JLL"), as an exclusive representative for the Owner, is pleased to present the offering of the Pharmaceutics International Headquarters (the "Portfolio"), pharmaceutical manufacturing investment opportunity with highly specialized and mission-critical space for the tenant. The three building, 206,114 SF opportunity consists of 103 Beaver Court, 10819 Gilroy Road, and 10950 Beaver Dam Road. The Portfolio is 100% leased to Pharmaceutics International Inc. ("Pii"), a subsidiary of Jabil, a multinational manufacturing company with $29.8 billion in net revenue in FY 2025. Pii's lease has a remaining term of 10.17 years, allowing an investor to take advantage of their long-term assured cash flow.

Pii is a contract development and manufacturing organization (CDMO) specializing in the research, development, and manufacturing of vials and syringes, oral solid dosage (tablets and capsules), and semi-solid medications. CDMOs handle the research, formulation, development, and scaling of a drug including optimizing the chemical makeup of a drug, large-scale production that complies with FDA or Good Manufacturing Practice (GMP) standards, and regulatory support. Each property has substantial capital invested in equipment and facility build-out, with uses spanning sterile manufacturing, laboratory, and general warehouse space, outfitted to meet GMP laboratory and storage standards, including special cold-temperature requirements.

The Portfolio is located in the I-83 Corridor submarket, one of the strongest industrial submarkets in the Baltimore market with a 95.3% occupancy rate, $12.70/SF NNN market rent, and 10.1 MSF of inventory. The submarket is characterized by both institutionally owned and owner-occupied flex, shallow-bay, and manufacturing product with both national and regional companies headquartered in Hunt Valley and Cockeysville.